Diagnosis and treatment of hyperhomocysteinemia

Hyperhomocysteinemia has emerged as an important risk factor for cardiovascular disease. However, its place in clinical practice is somewhat unclear, due to the lack of clinical trials documenting the benefit of treatment on reducing cardiovascular events. Vitamin therapy, particularly with folic ac...

Full description

Saved in:
Bibliographic Details
Published in:Current atherosclerosis reports 2001-01, Vol.3 (1), p.54-63
Main Authors: Keebler, M E, De Souza, C, Fonseca, V
Format: Article
Language:English
Subjects:
Biomarkers - blood
Homocysteine - blood
Humans
Hyperhomocysteinemia - diagnosis
Hyperhomocysteinemia - drug therapy
Vitamins - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hyperhomocysteinemia has emerged as an important risk factor for cardiovascular disease. However, its place in clinical practice is somewhat unclear, due to the lack of clinical trials documenting the benefit of treatment on reducing cardiovascular events. Vitamin therapy, particularly with folic acid, reduces plasma homocysteine significantly and improves other surrogate markers of cardiovascular risk such as endothelial function. Although a consensus is lacking on the right approach to diagnosis and treatment of this risk factor, we have suggested an algorithm based on data from clinical studies. We are optimistic that such an approach will be helpful for the clinician until clinical trials, with cardiovascular events as endpoints, are completed.
ISSN:1523-3804
1534-6242
DOI:10.1007/s11883-001-0011-1